Systemic hypoxia produces an inflammatory response characterized by increases in reactive O 2 species (ROS), venular leukocyte-endothelial adherence and emigration, and vascular permeability. Inflammation is typically initiated by mediators released from activated perivascular cells that generate the chemotactic gradient responsible for extravascular leukocyte accumulation.
INTRODUCTION
Systemic hypoxia produces a rapid inflammatory response in the mesenteric, pial, and skeletal muscle microcirculations (8) . This response includes increased leukocyte-endothelial adhesive interactions in post-capillary venules (29) , increased vascular permeability, and leukocyte emigration to the perivascular space (28) . Lipid inflammatory mediators such as platelet activating factor (PAF) (4) and leukotriene B 4 (LTB 4 ) (24) are involved in this response. Participation of reactive O 2 species (ROS) is supported by the observation of a hypoxia-induced increase in the fluorescence intensity of dihydrorhodamine (DHR), an oxidant-sensitive probe, and by the ability of antioxidants to attenuate both the increased DHR fluorescence and the microvascular inflammatory response (27) . The exact mechanism responsible for the increase in ROS is not clear; however, lipid inflammatory mediators could contribute to the development of oxidative stress during hypoxia.
Inflammatory mediators released from cells activated by a wide range of stimuli are responsible for the microvascular changes of inflammation (9) . These involve increased leukocyte endothelial-adhesive interactions and emigration of leukocytes to the perivascular space.
Leukocyte emigration occurs along a chemotactic gradient that is established by activated cells present in the interstitium. The nature of these extravascular cells, as well as the specific stimulus responsible for the hypoxic response, are not known. Mast cells are abundant in the induced activation of the probe. The fluorescence intensity was later measured during playback of videotapes using image analysis software (NIH Image, 1.62). The intensity of the fluorescent signal was measured in five adjacent circles of 5 µm diameter along the vessel and averaged to obtain a single estimate of the fluorescent signal during each experimental period. The same field of view was maintained throughout the experiment. Values for fluorescence during hypoxia and normoxic recovery were expressed relative to the value observed during the normoxic control period, defined as 100%.
Measurement of Mast Cell Degranulation:
Ruthenium red (0.001%) was added to the superfusate and images of the mesenteric microcirculation were then recorded every 2 min throughout the experiment. The images were converted to digitized gray scales and then phase-inverted (14) . The relative light intensity of each mast cell within the field of view was measured and the degree of mast cell activation was calculated as the ratio of experimental/control intensities.
Measurement of leukocyte emigration/vascular permeability:
Leukocyte emigration was assessed from video recordings by counting the number of leukocytes in an area defined as 100 µm along the venule by 40 µm away from the vessel.
Emigration was then expressed as the number of extravascular leukocytes per 4 x 10 3 µm 2 . Five venules were analyzed in each rat, and the results were then averaged to obtain an estimate of leukocyte emigration for each animal.
FITC-labeled bovine albumin (50 mg/kg) was injected i.v. to conscious rats 30 min before examining the mesenteric microcirculation. Using an ICCD camera, fluorescence intensity was recorded at an excitation wavelength of 420-490 nm and an emission wavelength of 520 nm.
Duration of fluorescence recordings was <15 s in a given area. The fluorescence intensity in three separate venules and surrounding areas was measured in each rat using NIH Image 1.62 and the values were averaged. The vascular permeability index was then calculated as the ratio of extravascular to intravascular fluorescence intensities (28) .
Drugs and Chemicals:
Compound 48/80, cromolyn sodium, ruthenium red, lipoic acid (thioctic acid), FITC-albumin, phosphate-buffered saline (PBS), and urethane were purchased from Sigma. 
Experimental Protocols

Effects of compound 48/80 and cromolyn on mast cell degranulation under normoxic conditions:
In all protocols, experiments began after a 30-min post-surgery stabilization period. The animals spontaneously breathed through a two-way valve (2384 series, Hans Rudolph, Kansas City, MO), which was attached to the tracheal tube.
This experimental protocol consisted of a 10-min control period, followed by superfusion of ruthenium red over the mesentery for 15-min, followed by superfusion of compound 48/80 for 10 min. Compound 48/80 was removed the superfusate and the experiment continued for another 10 min. In a separate group of animals, the same protocol was followed, except that the must cell stabilizer cromolyn was administered i.v. as a bolus (40 mg/kg) at the beginning of the experiment followed by a continuous infusion (0.8 mg/kg/h). The extent of mast cell degranulation was measured every 2 min throughout the experiments as described above.
Does mast cell degranulation in normoxia produce microvascular responses similar to those induced by systemic hypoxia?
The protocol of these experiments consisted of an initial 10-min normoxic control period in which the animals breathed room air, a 20-min equilibration period after i.v. injection of DHR (10 µg/kg), a 10-min hypoxic period (10% O 2 -90% N 2 ) followed by a 10-min normoxic recovery period.
Recordings of DHR fluorescence were made at the end of the normoxic, hypoxic, and normoxic recovery periods.
An additional series of experiments was carried out to study leukocyte-endothelial adherence as described above. This protocol consisted of a 10-min normoxic period, a 10-min hypoxia period, followed by a 10-min normoxic recovery period. .
In a third series of experiments, after a control period of 10 min, the mesentery was 
Does systemic hypoxia induce mast cell degranulation?
This experimental protocol consisted of a 10-min normoxic period, a 10-min hypoxia period, followed by a 10-min normoxic recovery period. Ruthenium red was superfused over the mesentery in these experiments in order to assess the degree of mast cell activation as described above.
Does prevention of mast cell degranulation block the microvascular response to systemic hypoxia?
In a first series of experiments, the protocol described for the hypoxia experiments was used to determine the effect of the mast cell stabilizer cromolyn on hypoxia-induced increase in ROS levels, mast cell degranulation, and leukocyte-endothelial adherence. Cromolyn was administered as described above. Microvascular ROS levels or mast cell degranulation and leukocyte adherence were measured in separate groups of animals.
A second set of experiments assessed the role of mast cells on hypoxia-induced leukocyte emigration and increased vascular permeability. On the day before the experiment the rats were anesthetized with xylazine-ketamine (2 mg/kg body wt i.m.), and PE-50 catheters were placed in a jugular vein and a carotid artery and tunneled to the back of the neck. On the next morning, the animals were randomly assigned to protocols designed to determine leukocyte emigration and vascular permeability as described above. The rats were placed in a chamber in which 10% O 2 was continuously circulated. After 3.5 h, FITC-albumin was injected i.v; at 4 h of hypoxia, the rats were quickly anesthetized (urethane, 1 g/kg i.v.) and prepared for intravital microscopy. Vascular permeability and leukocyte emigration were measured as described above. To minimize exposure of the animals to room air, the measurements were completed within 15 min of induction of anesthesia. Parallel experiments were conducted in rats exposed to room air as well as in rats given cromolyn throughout the hypoxia period.
Do changes in the ROS/NO balance contribute to mast cell stimulation in hypoxia?
After the normoxic period, SNO (100 µM superfusion) or lipoic acid (2 mg/kg i.v.) were administered to animals beginning 20-min prior to hypoxic challenge. Rats then breathed 10% O 2 for 10-min, followed by a 10-min normoxic recovery period. Mast cell activation was measured as described above.
Statistical Analysis:
Data are presented as means and SEMs. Analysis of variance with Bonferroni's test for multiple comparisons was used to compare differences between groups (Statistix 4.0, Analytical Software, St. Paul, MN). Values of P<0.05 were considered to be statistically significant.
RESULTS
Effects of compound 48/80 and cromolyn on mast cell degranulation under normoxic conditions:
Compound 48/80 was used in these experiments to activate mast cells . 
Does mast cell degranulation in normoxia produce microvascular responses similar to those induced by systemic hypoxia?
Systemic hypoxia results in increased ROS levels in the mesenteric microcirculation 
Does prevention of mast cell degranulation block the microvascular response to systemic hypoxia?
Figure 6 shows that ten minutes of hypoxia result in an increase in DHR fluorescence intensity to 154 ± 12% above control (P<0.05, n=6). This increase is reversible, and after 10 min of normoxia, DHR fluorescence intensity has decreased significantly from the hypoxic levels ( Figure   6 ). Pretreatment with cromolyn significantly limits the hypoxia-induced increase in DHR fluorescence intensity to 114 ± 5% of control (Figure 6 ; P>0.05, n=6), indicating that prevention of hypoxia-induced mast cell degranulation abolishes the increase in microvascular ROS levels associated with hypoxia.
Cromolyn also significantly inhibits hypoxia-induced leukocyte adherence (Figure 3) , as well as the leukocyte adherence secondary to compound 48/80 administration (Figures 1 and 3 ). This observation links mast cell degranulation to the increase in leukocyte-endothelial interactions that accompanies systemic hypoxia.
Conscious rats exposed to hypoxia for 4 h showed a significant increase in leukocyte .05 hypoxia + cromolyn vs control, n=6), which, although significantly lower than that of the untreated hypoxic rats, was significantly higher than that of the normoxic controls.
In summary, the data obtained in this section indicate that prevention of mast cell degranulation either blocks or attenuates the microvascular responses to systemic hypoxia. A second piece of evidence supporting a causal relationship between mast cell activation and hypoxia-induced microvascular inflammation was the demonstration that systemic hypoxia produces rapid mast cell degranulation (Figures 4 and 5) . The time course of mast cell degranulation corresponds closely to that of the increase in leukocyte-endothelial adherence during systemic hypoxia, and provides support for a link between these two phenomena. Furthermore, mast cell degranulation induced by compound 48/80 promotes leukocyte-endothelial adhesive interactions with a time course similar to that of hypoxia-induced mast cell degranulation ( Figure 3 ). Accordingly, activation of mast cells, whether produced by hypoxia or compound 48/80, is rapidly followed by increased leukocyte-endothelial adherence. These two events are highly correlated, as illustrated in Figure 10 The increase in ROS during systemic hypoxia observed in these experiments confirms our previous observations (24, 25, 27) and those of others (2, 6, 26) . The ability of cromolyn to block the hypoxia-induced increase in leukocyte adherence supports a role of activated mast cells in this phenomenon. In general, adherence of leukocytes to the endothelium is followed by emigration to the perivascular space along a chemotactic gradient generated by the presence of activated cells outside the vessel. Cromolyn blocked the leukocyte emigration in conscious rats exposed to 4 h of hypoxia. This could be due to the inhibitory effect of cromolyn on leukocyte adherence (Figure 3) . In addition, cromolyn could have prevented the development of the chemotactic gradient necessary for leukocyte emigration, suggesting that activated mast cells have a role in generating this gradient.
Do changes in the ROS
Cromolyn attenuated, but did not totally prevent, the increase in vascular permeability of systemic hypoxia, indicating the participation of factors in addition to mast cell activation. A direct effect of hypoxia on vascular permeability is suggested by the observation that cultured endothelial cells show an increase in permeability in response to reductions in PO 2 (21) . Formation of gaps between endothelial cells has been shown to be necessary for both the increase in permeability and the leukocyte emigration during inflammation (9) . The dissociation between increases in vascular permeability and leukocyte emigration when hypoxia-induced mast cell degranulation was prevented (Figures 7 and 8) indicate that increased permeability is a necessary but not sufficient factor in the process of leukocyte emigration. The results obtained here support the possibility that activation of mast cells contributes to generate the chemotactic gradient necessary for leukocyte recruitment into tissue during systemic hypoxia.
While the results show that mast cells are activated in hypoxia, the mechanism underlying this response is unclear. The ability of lipoic acid and of the NO donor to prevent mast cell degranulation during hypoxia points to an involvement of the ROS/NO balance in mast cell activation. These results are consistent with previous observations of blockade of mast cell activation by antioxidants (16, 23) and NO (7, 22) , as well as enhanced degranulation of mast cells following inhibition of NO synthase (3, 13, 22) . Indirect evidence for a participation of ROS in mast cell degranulation is provided by the DHR fluorescence images of the microcirculation obtained in this study (Figure 11) . It is clear that hypoxia and compound 48/80 administration are accompanied by increases in ROS levels at the vessel wall, where leukocyte-endothelial adhesive interactions take place. However, close inspection of these images shows discrete areas of increased fluorescence in the extravascular compartment. Fluorescence intensity at these sites is attenuated by cromolyn, suggesting that fluorescence originates either in activated mast cells, or in cells that generate ROS after mast cell activation in response to hypoxia or compound 48/80 (Figure 11 ).
It is clear that further research is needed to determine the mechanism of mast cell activation during hypoxia. If changes in the mast cell ROS/NO balance are early events in the initiation of the hypoxic inflammatory response, as suggested by the present experiments, a possible sequence of events would involve an initial increase in mast cell ROS levels which would trigger mast cell activation, release of inflammatory mediators, and further elevation of ROS levels and depletion of NO within the microcirculation. This scenario would explain the ability of antioxidants and the mast cell stabilizer to block mast cell activation as well as the microvascular inflammatory response.
This would imply that ROS participate in signal transduction during hypoxia, a role suggested by a recent series of studies (2, 6, 26) .
In summary, the results presented here strongly support the participation of mast cells in the microvascular effects of systemic hypoxia, and provide additional evidence on the inflammatory nature of this response. This issue is highly relevant since an inflammatory component has been proposed for the various acute conditions occurring at altitude, including acute mountain sickness and high altitude cerebral edema, which are characterized by abnormal body fluid balance and increased vascular permeability. While the early microvascular inflammation of hypoxia appears to be a deleterious response, it is interesting that prolonged exposure to hypoxia in rats leads to acclimatization of the vascular endothelium, with the inflammatory lesion resolving and the animals becoming resistant to even more severe hypoxia (29) . It could be hypothesized that the early y microvascular inflammatory response initiates the cascade of events that leads to acclimatization of vascular endothelial function. In this light, it is important to note that acute mountain sickness and high altitude cerebral edema do not occur in acclimatized individuals. There is no effect of lipoic acid or SNO during normoxia on mast cell degranulation.
Both lipoic acid and SNO prevented hypoxia-induced mast cell degranulation. As expected based on previous studies, no adherent leukocytes were observed during hypoxia in animals treated with SNO or lipoic acid. 
